Clinical Trial Update: Preventing Sexual Dysfunction With Aromatase Inhibitors [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial at MD Anderson explored preventing sexual dysfunction in patients receiving aromatase inhibitors for breast cancer; the trial has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Aromatase inhibitors (aromatase inhibitor)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED